{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:02:23Z","timestamp":1780466543005,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0894-5","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T02:24:34Z","timestamp":1461896674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["En bloc pelvic resection for advanced ovarian cancer preceded by central ligation of vessels supplying the tumor bed: a description of surgical technique and a feasibility study"],"prefix":"10.1186","volume":"14","author":[{"given":"Jacek Jan","family":"Sznurkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"894_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"894_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","volume":"47","author":"WJ Hoskins","year":"1992","unstructured":"Hoskins WJ, Bundy BN, Thigpen JT, Omura GA. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 1992;47:159\u201366.","journal-title":"Gynecol Oncol"},{"key":"894_CR3","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2003;21:3194\u2013200.","journal-title":"J Clin Oncol"},{"key":"894_CR4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/gyno.2001.6328","volume":"82","author":"DS Chi","year":"2001","unstructured":"Chi DS, Liao JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol. 2001;82:532\u20137.","journal-title":"Gynecol Oncol"},{"key":"894_CR5","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","volume":"25","author":"WE Winter III","year":"2007","unstructured":"Winter III WE, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2007;25:3621\u20137.","journal-title":"J Clin Oncol"},{"key":"894_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","volume":"103","author":"DS Chi","year":"2006","unstructured":"Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559\u201364.","journal-title":"Gynecol Oncol"},{"key":"894_CR7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248\u201359.","journal-title":"J Clin Oncol"},{"key":"894_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3802\/jgo.2015.26.2.155","volume":"26","author":"SJ Chang","year":"2015","unstructured":"Chang SJ, Bristow RE. Surgical technique of en bloc pelvic resection for advanced ovarian cancer. J Gynecol Oncol. 2015;26:155. doi: 10.3802\/jgo.2015.26.2.155 .","journal-title":"J Gynecol Oncol"},{"key":"894_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7800-2-5","volume":"2","author":"G Atkin","year":"2005","unstructured":"Atkin G, Chopada A, Mitchell I. Colorectal cancer metastasis: in the surgeon\u2019s hands? Int Semin Surg Oncol. 2005;2:5.","journal-title":"Int Semin Surg Oncol"},{"key":"894_CR10","first-page":"723","volume":"94","author":"JP Barnes","year":"1952","unstructured":"Barnes JP. Physiologic resection of the right colon. Surg Gynecol Obstet. 1952;94:723\u20136.","journal-title":"Surg Gynecol Obstet"},{"issue":"5","key":"894_CR11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamasurg.2013.3643","volume":"149","author":"TM Gall","year":"2014","unstructured":"Gall TM, Jacob J, Frampton AE, Krell J, Kyriakides C, Castellano L, Stebbing J, Jiao LR. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. JAMA Surg. 2014;149(5):482\u20135.","journal-title":"JAMA Surg"},{"issue":"1","key":"894_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jjco\/hyt156","volume":"44","author":"Y Takii","year":"2014","unstructured":"Takii Y, Shimada Y, Moriya Y, Nakamura K, Katayama H, Kimura A, et al. A randomized controlled trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colorectal cancer: Japan Clinical Oncology Group Study JCOG1006. Jpn J Clin Oncol. 2014;44(1):97\u2013100.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"894_CR13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jpainsymman.2014.06.006","volume":"49","author":"J Young","year":"2015","unstructured":"Young J, Badgery-Parker T, Dobbins T, Jorgensen M, Gibbs P, Faragher I, Jones I, Currow D. Comparison of ECOG\/WHO performance status and ASA score as a measure of functional status. J Pain Symptom Manage. 2015;49(2):258\u201364.","journal-title":"J Pain Symptom Manage"},{"key":"894_CR14","volume-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH. An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy. In: Sugarbaker PH, editor. Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas. Woodbury: Cine-Med Publishers; 2012."},{"issue":"2 Suppl","key":"894_CR15","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.ygyno.2008.07.055","volume":"111","author":"MS Hoffman","year":"2008","unstructured":"Hoffman MS, Zervose E. Colon resection for ovarian cancer: intraoperative decisions. Gynecol Oncol. 2008;111(2 Suppl):S56\u201365.","journal-title":"Gynecol Oncol"},{"key":"894_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2013.01.024","volume":"129","author":"F Raspagliesi","year":"2013","unstructured":"Raspagliesi F, Ditto A, Martinelli F, Haeusler E, Lorusso D. Advanced ovarian cancer: omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor. Gynecol Oncol. 2013;129:92\u20136.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"894_CR17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ygyno.2014.11.072","volume":"136","author":"LM Chiva","year":"2015","unstructured":"Chiva LM, Gonzalez-Martin A. A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer. Gynecol Oncol. 2015;136(1):130\u20135.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"894_CR18","first-page":"400","volume":"35","author":"Y Yildirim","year":"2014","unstructured":"Yildirim Y, Ertas IE, Nayki U, Ulug P, Nayki C, Yilmaz I, et al. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer. Eur J Gynaecol Oncol. 2014;35(4):400\u20137.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"894_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/gyno.2001.6469","volume":"84","author":"RD Clayton","year":"2002","unstructured":"Clayton RD, Obermair A, Hammond IG, Leung YC, McCartney AJ. The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol. 2002;84(1):53\u20137.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"894_CR20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1072-7515(03)00478-2","volume":"197","author":"RE Bristow","year":"2003","unstructured":"Bristow RE, del Carmen MG, Kaufman HS, Montz FJ. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg. 2003;197(4):565\u201374.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"894_CR21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2005.07.112","volume":"99","author":"SM Mourton","year":"2005","unstructured":"Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, Bochner BH, et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2005;99(3):608\u201314.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"894_CR22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ygyno.2006.06.004","volume":"103","author":"JY Park","year":"2006","unstructured":"Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, et al. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Gynecol Oncol. 2006;103(3):977\u201384.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"894_CR23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2006.05.003","volume":"103","author":"DL Richardson","year":"2006","unstructured":"Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006;103(2):667\u201372.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"894_CR24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ygyno.2012.04.030","volume":"126","author":"M Peiretti","year":"2012","unstructured":"Peiretti M, Bristow RE, Zapardiel I, Gerardi M, Zanagnolo V, Biffi R, et al. Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes. Gynecol Oncol. 2012;126(2):220\u20133.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"894_CR25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag. 2006;2(3):213\u20139.","journal-title":"Vasc Health Risk Manag"},{"key":"894_CR26","doi-asserted-by":"crossref","unstructured":"Matos D, Atallah \u00c1N, Castro AA, Silva Lustosa SA. Stapled versus handsewn methods for colorectal anastomosis surgery. Cochrane Database Syst Rev. 2001;Issue 3. Art. No.: CD003144. doi: 10.1002\/14651858.CD003144 .","DOI":"10.1002\/14651858.CD003144"},{"issue":"2","key":"894_CR27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.clnu.2006.01.015","volume":"25","author":"A Weimann","year":"2006","unstructured":"Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P, et al. ESPEN Guidelines on Enteral Nutrition: surgery including organ transplantation. Clin Nutr. 2006;25(2):224\u201344.","journal-title":"Clin Nutr"},{"issue":"9","key":"894_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4240\/wjgs.v4.i9.208","volume":"4","author":"F Goulder","year":"2012","unstructured":"Goulder F. Bowel anastomoses: the theory, the practice and the evidence base. World J Gastrointest Surg. 2012;4(9):208\u201313.","journal-title":"World J Gastrointest Surg"},{"key":"894_CR29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00595-008-3835-2","volume":"39","author":"P Taflampas","year":"2009","unstructured":"Taflampas P, Christodoulakis M, Tsiftsis DD. Anastomotic leakage after low anterior resection for rectal cancer: facts, obscurity, and fiction. Surg Today. 2009;39:183\u20138.","journal-title":"Surg Today"},{"issue":"1","key":"894_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2013.07.086","volume":"131","author":"G Hofstetter","year":"2013","unstructured":"Hofstetter G, Concin N, Braicu I, Chekerov R, Sehouli J, Cadron I, et al. The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma\u2014analysis of patient data in the prospective OVCAD study. Gynecol Oncol. 2013;131(1):15\u201320.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"894_CR31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2012.07.023","volume":"49","author":"S Mahner","year":"2013","unstructured":"Mahner S, Eulenburg C, Staehle A, Wegscheider K, Reuss A, Pujade-Lauraine E, et al. Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomized phase III trials. Eur J Cancer. 2013;49(1):142\u20139. doi: 10.1016\/j.ejca.2012.07.023 .","journal-title":"Eur J Cancer"},{"key":"894_CR32","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois du","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer. 2009;115:1234\u201344.","journal-title":"Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0894-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T23:56:37Z","timestamp":1567814197000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-016-0894-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0894-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"article-number":"133"}}